EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vaccinia virus armed with IL-21 can cure murine colorectal cancer liver metastases via intravenous administration

Na Wang, Yijia He, Junzhi Yu, Yimeng Xia, Yangyang Jia, Ruixian Liu, Yanru Zhang, Yan Liu, Shiyang Ning, Louisa S Chard Dunmall, Zhe Zhang, Yaohe Wang

Journal for ImmunoTherapy of Cancer · 2026

DOI: 10.1136/jitc-2025-012479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Na Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Vaccinia virus, Colorectal Neoplasms, Interleukins, Oncolytic Virotherapy. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhengzhou University, Science and Technology Breakthrough Project of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver metastases of colorectal cancer are one of the leading causes of mortality in patients with colorectal cancer. Oncolytic virus immunotherapy has demonstrated significant potential in tumor treatment; however, most oncolytic viruses are currently administered via intratumoral injection, limiting their broader clinical application.

Methods

In this study, we used an oncolytic vaccinia virus VVLΔTK-STCΔN1L-mIL21 expressing interleukin-21 to treat a male BALB/c murine model of colorectal cancer liver metastases (CRLM) via intravenous administration. This approach aimed to explore the feasibility of oncolytic viruses reaching distant tumors through systemic delivery and exerting therapeutic effects, thereby broadening the application scope of oncolytic viruses. We examined the effects of intravenous vaccinia virus treatment on the survival of mice with colorectal cancer liver metastases. Furthermore, we performed comprehensive analyses of the impacts of vaccinia virus therapy on T lymphocytes in these mice using flow cytometry, in vitro interferon (IFN)-γ release assays, and RNA sequencing.

Results

Our findings revealed that VVLΔTK-STCΔN1L-mIL21, when administered intravenously, successfully reached liver tumor foci and persisted for an extended period, significantly prolonging the survival of mice with CRLM. Further analysis showed that VVLΔTK-STCΔN1L-mIL21 treatment promoted the expansion of CD8 + T cells and effector memory T cells (CD8 + CD44 hi CD62L lo T EM ) while reducing regulatory T cells. It also enhanced the secretion of IFN-γ by splenic CD45 + lymphocytes in vitro, inhibited the expression of immune checkpoint molecules and effector molecules on CD8 + T cells, and promoted the generation of T follicular helper cells.

Conclusions

VVLΔTK-STCΔN1L-mIL21 can effectively reach liver metastases via tail vein injection and exert potent antitumor effects, significantly extending the survival of mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccinia virusColorectal NeoplasmsInterleukinsOncolytic VirotherapyLiver NeoplasmsAnimalsMiceInterleukin-21MaleAdministration, IntravenousMice, Inbred BALB COncolytic VirusesHumansDisease Models, AnimalCell Line, Tumor

Stichwörter der Autor:innen

Colorectal CancerImmunotherapyMemoryT cell

Substanzen

Interleukin-21Interleukins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China.
  • Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China yaohe.wang@qmul.ac.uk fbsktz@163.com.
  • Centre for Cancer Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK yaohe.wang@qmul.ac.uk fbsktz@163.com.

Förderung

  • Zhengzhou University
  • Science and Technology Breakthrough Project of Henan Province

Zitieren

APA

Wang, N., He, Y., Yu, J., Xia, Y., Jia, Y., Liu, R., Zhang, Y., Liu, Y., Ning, S., Chard Dunmall, L. S., Zhang, Z., & Wang, Y. (2026). Vaccinia virus armed with IL-21 can cure murine colorectal cancer liver metastases via intravenous administration. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012479

Vancouver

Wang N, He Y, Yu J, Xia Y, Jia Y, Liu R, et al. Vaccinia virus armed with IL-21 can cure murine colorectal cancer liver metastases via intravenous administration. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2025-012479

BibTeX
@article{Wang2026,
  author = {Wang, Na and He, Yijia and Yu, Junzhi and Xia, Yimeng and Jia, Yangyang and Liu, Ruixian and Zhang, Yanru and Liu, Yan and Ning, Shiyang and Chard Dunmall, Louisa S and Zhang, Zhe and Wang, Yaohe},
  title = {Vaccinia virus armed with IL-21 can cure murine colorectal cancer liver metastases via intravenous administration},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  doi = {10.1136/jitc-2025-012479}
}
Kostenlos starten →